shortagewatch

Home / Anti-infectives / Immunoglobulins, Normal Human, for Intravascular Adm.

ATC J06BA02 · Immune Sera and Immunoglobulins

Immunoglobulins, Normal Human, for Intravascular Adm. shortage

As of 31 Oct 2026, Immunoglobulins, Normal Human, for Intravascular Adm. has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 59 products.

Countries4/5
Products59packs or presentations
Short since10 Apr 20197.6 years ago
Earliest return30 Dec 2026company estimate
No return date30products
Main reasonActive ingredient shortage

Timeline

ItalySpainAustriaBelgium
20222023202420252026KIOVIGKIOVIGKIOVIGKIOVIGIG VENAIG VENAFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFFLEBOGAMMA DIFGAMMAGARDGAMMAGARDGAMMAGARDGAMMAGARDIQYMUNEIQYMUNEIQYMUNEIQYMUNEGAMUNEXGAMUNEXGAMUNEXGAMUNEXIQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1 vial de 200 mlIQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1 vial de 100 mlOCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSIOOCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 100 mlOCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSIOOCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 20 mlOCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSIOOCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 200 mlOCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSIOOCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 50 mlOCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSIONOCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 100 mlOCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSIONOCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 200 mlOCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSIONOCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 50 mlKIOVIG 100 mg/ml Infusionslösung, 1 StückKIOVIG 100 mg/ml Infusionslösung, 1 StückKIOVIG 100 mg/ml Infusionslösung, 1 StückKIOVIG 100 mg/ml Infusionslösung, 1 StückKIOVIG 100 mg/ml Infusionslösung, 1 StückKIOVIG 100 mg/ml Infusionslösung, 1 StückKIOVIG 100 mg/ml Infusionslösung, 1 StückKIOVIG 100 mg/ml Infusionslösung, 1 Stücktoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITKIOVIGTAKEDA MANUFACTURING AUSTRIA AG10 Apr 2019not givenIncreased demand
Elevata richiesta: forniture discontinue
ITKIOVIGTAKEDA MANUFACTURING AUSTRIA AG10 Apr 2019not givenCommercial decision or withdrawal
Motivi commerciali: forniture discontinue
ITIG VENAKEDRION S.P.A.31 Jul 2019not givenIncreased demand
Elevata richiesta: forniture discontinue
ITFLEBOGAMMA DIFINSTITUTO GRIFOLS S.A.26 Nov 202031 Dec 2026Manufacturing problem
Problemi produttivi: forniture discontinue
ITFLEBOGAMMA DIFINSTITUTO GRIFOLS S.A.26 Nov 202031 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITFLEBOGAMMA DIFINSTITUTO GRIFOLS S.A.26 Nov 202031 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITFLEBOGAMMA DIFINSTITUTO GRIFOLS S.A.26 Nov 202031 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITFLEBOGAMMA DIFINSTITUTO GRIFOLS S.A.26 Nov 202031 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITFLEBOGAMMA DIFINSTITUTO GRIFOLS S.A.26 Nov 202031 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITFLEBOGAMMA DIFINSTITUTO GRIFOLS S.A.26 Nov 202031 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITFLEBOGAMMA DIFINSTITUTO GRIFOLS S.A.26 Nov 202031 Dec 2026Manufacturing problem
Problemi produttivi: forniture discontinue
ITGAMMAGARDBAXALTA INNOVATIONS GMBH1 Jul 2022not givenIncreased demand
Elevata richiesta: forniture discontinue
ITGAMMAGARDBAXALTA INNOVATIONS GMBH31 Oct 2022not givenIncreased demand
Elevata richiesta: forniture discontinue
ITIQYMUNELABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES1 Sep 20251 Mar 2027Manufacturing problem
Problemi produttivi
ITIQYMUNELABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES1 Sep 20251 Mar 2027Manufacturing problem
Problemi produttivi
ITGAMUNEXGRIFOLS DEUTSCHLAND GMBH14 Nov 202531 Dec 2026Manufacturing problem
Problemi produttivi: forniture discontinue
ITGAMUNEXGRIFOLS DEUTSCHLAND GMBH14 Nov 202531 Dec 2026Manufacturing problem
Problemi produttivi: forniture discontinue
ESIQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1 vial de 200 mlLaboratoire Francais Du Fractionnement Et Des Biotechnologies23 Sep 202514 Mar 2027Not stated
ESIQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1 vial de 100 mlLaboratoire Francais Du Fractionnement Et Des Biotechnologies30 Sep 202514 Mar 2027Not stated
ESOCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 100 mlOctapharma S.A.6 Jul 202630 Dec 2026Not stated
ESOCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 20 mlOctapharma S.A.6 Jul 202630 Dec 2026Not stated
ESOCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 200 mlOctapharma S.A.6 Jul 202630 Dec 2026Not stated
ESOCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 50 mlOctapharma S.A.6 Jul 202630 Dec 2026Not stated
ESOCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 100 mlOctapharma S.A.6 Jul 202630 Dec 2026Not stated
ESOCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 200 mlOctapharma S.A.6 Jul 202630 Dec 2026Not stated
ESOCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 50 mlOctapharma S.A.6 Jul 202630 Dec 2026Not stated
ATKIOVIG 100 mg/ml Infusionslösung, 1 StückTakeda Manufacturing Austria AG23 Oct 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATKIOVIG 100 mg/ml Infusionslösung, 1 StückTakeda Manufacturing Austria AG23 Oct 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATKIOVIG 100 mg/ml Infusionslösung, 1 StückTakeda Manufacturing Austria AG23 Oct 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATKIOVIG 100 mg/ml Infusionslösung, 1 StückTakeda Manufacturing Austria AG23 Oct 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATKIOVIG 100 mg/ml Infusionslösung, 1 StückTakeda Manufacturing Austria AG23 Oct 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATPrivigen 100 mg/ml Infusionslösung, 1 StückCSL Behring GmbH3 Nov 202031 Mar 2027Active ingredient shortage
Verknappung des Wirkstoffes
ATPrivigen 100 mg/ml Infusionslösung, 1 StückCSL Behring GmbH3 Nov 202031 Mar 2027Active ingredient shortage
Verknappung des Wirkstoffes
ATPrivigen 100 mg/ml Infusionslösung, 1 StückCSL Behring GmbH3 Nov 202031 Mar 2027Active ingredient shortage
Verknappung des Wirkstoffes
ATPrivigen 100 mg/ml Infusionslösung, 1 StückCSL Behring GmbH3 Nov 202031 Mar 2027Active ingredient shortage
Verknappung des Wirkstoffes
ATPrivigen 100 mg/ml Infusionslösung, 1 StückCSL Behring GmbH3 Nov 202031 Mar 2027Active ingredient shortage
Verknappung des Wirkstoffes
ATIg Vena 50 g/l Infusionslösung, 1 StückKedrion S.p.A.20 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATIg Vena 50 g/l Infusionslösung, 1 StückKedrion S.p.A.20 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATIg Vena 50 g/l Infusionslösung, 1 StückKedrion S.p.A.20 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATIg Vena 50 g/l Infusionslösung, 1 StückKedrion S.p.A.20 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATIntratect 100 g/l Infusionslösung, 1 StückBiotest Pharma GmbH24 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATIntratect 100 g/l Infusionslösung, 1 StückBiotest Pharma GmbH24 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATIntratect 100 g/l Infusionslösung, 1 StückBiotest Pharma GmbH24 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATIntratect 50 g/l Infusionslösung, 1 StückBiotest Pharma GmbH24 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATIntratect 50 g/l Infusionslösung, 1 StückBiotest Pharma GmbH24 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATIntratect 50 g/l Infusionslösung, 1 StückBiotest Pharma GmbH24 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATIntratect 50 g/l Infusionslösung, 1 StückBiotest Pharma GmbH24 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATGAMMAGARD S/D Pulver und Lösungsmittel zur Herstellung einer Infusionslösung, 1 StückBaxalta Innovations GmbH25 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATOctagam 100 mg/ml Infusionslösung, 1 StückOctapharma Pharmazeutika Produktionsgesellschaft m.b.H.27 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATOctagam 100 mg/ml Infusionslösung, 1 StückOctapharma Pharmazeutika Produktionsgesellschaft m.b.H.27 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATOctagam 100 mg/ml Infusionslösung, 1 StückOctapharma Pharmazeutika Produktionsgesellschaft m.b.H.27 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATOctagam 100 mg/ml Infusionslösung, 1 StückOctapharma Pharmazeutika Produktionsgesellschaft m.b.H.27 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATOctagam 5% Infusionslösung, 1 StückOctapharma Pharmazeutika Produktionsgesellschaft m.b.H.27 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATOctagam 5% Infusionslösung, 1 StückOctapharma Pharmazeutika Produktionsgesellschaft m.b.H.27 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATOctagam 5% Infusionslösung, 1 StückOctapharma Pharmazeutika Produktionsgesellschaft m.b.H.27 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATOctagam 5% Infusionslösung, 1 StückOctapharma Pharmazeutika Produktionsgesellschaft m.b.H.27 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATIQYMUNE 100 mg/ml Infusionslösung, 100 mlLaboratoire Francais Du Fractionnement Et Des Biotechnologies4 Oct 202131 Dec 2026Manufacturing problem
Kapazitätsengpässe bei der Herstellung
ATIQYMUNE 100 mg/ml Infusionslösung, 200 mlLaboratoire Francais Du Fractionnement Et Des Biotechnologies4 Oct 202131 Dec 2026Manufacturing problem
Kapazitätsengpässe bei der Herstellung
BEPanzyga 100 mg/ml inf. sol. i.v. vial 100 mlOctapharma Benelux1 Jan 202030 Sep 2030Other
Other reason

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply